Private finance: SkyCell, ForQaly Medical, Sapreme, Gene Solutions, CoreBone

Israel: CoreBone, a company that produces bioactive, coral-based bone graft material, has finalised an investment round of US$3.7m. The Guangzhou Sino-Israel Biotech Investment Fund (GIBF), which focuses on introducing Israeli medical technologies to the Chinese market, invested US$3m in CoreBone’s Chinese subsidiary, while The Trendlines Group and Agriline (a trust of which Vincent Tchenguiz is a discretionary beneficiary) invested US$700,000. Funds…

You must be a HMI Subscriber to view this content.

Subscribe Now »